CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
1-15 of 1208
An Exclusive Peer Dinner with Prof. Abigail Schwaede, MD, Discussing Advancing Treat-to-Target Care in Generalized Myasthenia Gravis
CME/CE In-Person EventAn Exclusive Peer Dinner with Prof. Abigail Schwaede, MD, Discussing Advancing Treat-to-Target Care in Generalized Myasthenia Gravis
September 23, 2026
Chicago, Illinois
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
CME/CE Virtual EventToday’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
September 24, 2026
06:00 PM - 07:00 PM ET
The Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC
CME/CE Virtual EventThe Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC
September 29, 2026
12:00 PM - 01:00 PM EDT
- CME/CE In-Person & Virtual Event
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
September 30, 2026
Orlando, Florida When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Virtual EventWhen “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
October 07, 2026
06:00 PM - 07:00 PM CEST
- advertisement
An Exclusive Peer Dinner with Gil I. Wolfe MD, FAAN, Discussing Advancing Treat-to-Target Care in Generalized Myasthenia Gravis
CME/CE In-Person EventAn Exclusive Peer Dinner with Gil I. Wolfe MD, FAAN, Discussing Advancing Treat-to-Target Care in Generalized Myasthenia Gravis
October 10, 2026
New York, New York
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
CME/CE In-Person EventAdvancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
October 22, 2026
Austin, Texas
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
CME/CE In-Person EventAdvancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
October 23, 2026
Houston, Texas
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
CME/CE In-Person EventAdvancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
October 24, 2026
Atlanta, Georgia
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
CME/CE In-Person EventAdvancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
November 05, 2026
Phoenix, Arizona
- advertisement
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
CME/CE In-Person EventAdvancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
November 07, 2026
Miami, Florida
- CME/CE In-Person Event
22nd Annual Women’s Health Annual Visit (WHAV)
November 13, 2026
Pasadena, California
- CME/CE In-Person Event
22nd Annual Women’s Health Annual Visit (WHAV)
December 04, 2026
New York, New York



















